- Biographical profile
- Open Access
Lawson Wilkins: portrait of a pioneer
© Fuqua and Lee; licensee BioMed Central Ltd. 2014
- Published: 28 May 2014
- Growth Hormone
- Growth Hormone Deficiency
- Congenital Adrenal Hyperplasia
- Congenital Hypothyroidism
No doubt that Dr. Wilkins saw tremendous changes over the course of his medical career, perhaps the most important one being the development of antibiotics, which saved the lives of countless children. But Dr. Wilkins himself was the driver of changes in endocrine practice. In fact, while trying to learn from his predecessors about endocrinology in children, he ended up throwing an existing text of endocrine disease against the wall in frustration and decided to write his own based on his collection of painstakingly-developed case observations. This work eventually led to the first textbook of Pediatric Endocrinology and stimulated interest in the subspecialty around the world. But if he could have travelled forward in time to 2013, what would he think of where we are now?
He would certainly have been amazed by the technology. Measurement of hormones in his day relied on relatively primitive time and labor-intensive chromatographic and colorimetric techniques. Radioimmunoassays were perfected after his death, and platform-based immunoassays and tandem mass spectrometry were not even dreams. He might have been jealous of our ability to draw a blood sample and know the 17-hydroxyprogesterone or T4 concentration on the same day! As noted above, much of Dr. Wilkins’ early work in Pediatric Endocrinology was in the area of hypothyroidism, particularly congenital hypothyroidism, and we think he would be happy to see that universal newborn screening has essentially eliminated cretinism. Another area of focus was growth and its disorders. He lived to see the early use of pituitary-derived growth hormone in the treatment of growth hormone deficiency, and another of his protégés, Dr. Blizzard, was instrumental in the foundation and direction of the National Pituitary Agency. Our current detailed understanding of growth hormone secretion, physiology of the GH-IGF axis, and molecular genetics of growth disorders would have answered many of his questions but no doubt would have brought on new ones. Much of Dr. Wilkins’ academic career was spent in the investigation of adrenal disorders, puzzling out the now well-known steroidogenic pathways and devising treatment approaches for congenital adrenal hyperplasia. He probably would be gratified that the therapies he developed are not much different today, but might have been disappointed that even now CAH treatment is less than perfect.
There are also aspects of our specialty and medicine in general that we think would disappoint him. The Pediatric Endocrine Clinic at Johns Hopkins in the 1950s was an intellectually stimulating place. The Saturday Clinic was a venue that brought together a cohort of bright, curious physicians who, led by Dr. Wilkins, would brainstorm ideas about normal and abnormal physiology, new treatment approaches, and ideas to answer the many unknowns through clinical and basic research. Dr. Wilkins would regret the present-day outside influences pushing higher the number of patients to be seen in a limited time and the resulting lack of time afforded to critical thinking about our patients and their problems. Additionally, Dr. Wilkins was a premier physical diagnostician, and he was able to learn tremendously from studying the natural history of his patients. Today, he might have perceived a shift of focus from the patient’s overall clinical picture as illustrated by fundamental historical and physical examination findings to at times excessive reliance on laboratory test results and attention to minor lab abnormalities.
Overall, if Dr. Wilkins could see where we have come in the 50 years since his death, we think he would be very gratified to see the growth of the subspecialty that he, along with colleagues in Boston and in Europe, founded. In the US, the American Board of Pediatrics notes that there are now nearly 1500 board certified pediatric endocrinologists. He might also be surprised to learn that just over 50% of them are women, and this might cause him to reconsider his opinion that women should not be examining male genitalia!
It has been common for pediatric endocrinologists to figure out how many professional generations removed they were from Dr. Wilkins. Did you train with one of his protégés? With a protégé of a protégé? As the years have passed, however, the memory of Dr. Wilkins has begun to fade. Because of this, we hope you will read this collection of reminiscences and gain new insights into the birth of our profession under the guidance of a brilliant physician.
This article has been published as part of International Journal of Pediatric Endocrinology Volume 2014 Supplement 1, 2014: Remembering Doctor Lawson Wilkins: a pioneer of pediatric endocrinology. The full contents of the supplement are available online at http://www.ijpeonline.com/supplements/2014/S1.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.